Android app Apple app link

Neumora Therapeutics, Inc. Common Stock (NMRA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$2.48

north_east
$0.31 (14.29%)
Day's range
$2.19
Day's range
$2.59

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/02/2025 RBC Capital Brian Abrahams $4.00 $1.97   103.05%
07/22/2024 Needham Ami Fadia $23.00 $11.28   103.9%
07/08/2024 Mizuho Securities Graig Suvannavejh $20.00 $10.25   95.12%
06/17/2024 RBC Capital Brian Abrahams $29.00 $9.71   198.66%
03/13/2024 RBC Capital Brian Abrahams $31.00 $14.81   109.32%
10/10/2023 Stifel Nicolaus Paul Matteis $26.00 $10.91   138.31%
10/10/2023 RBC Capital Brian Abrahams $24.00 $10.91   119.98%

Neumora Therapeutics, Inc. Common Stock FAQ's

Neumora Therapeutics, Inc. Common Stock has been rated by research analysts at Stifel Nicolaus, RBC Capital, Needham, Mizuho Securities in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.